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Enzyme catalysed Pictet-Spengler formation
of chiral 1,1’-disubstituted- and spiro-
tetrahydroisoquinolines
Benjamin R. Lichman1,w, Jianxiong Zhao2, Helen C. Hailes2 & John M. Ward1
The Pictet–Spengler reaction (PSR) involves the condensation and ring closure between
a b-arylethylamine and a carbonyl compound. The combination of dopamine and ketones in
a PSR leads to the formation of 1,10-disubstituted tetrahydroisoquinolines (THIQs), structures
that are challenging to synthesize and yet are present in a number of bioactive natural
products and synthetic pharmaceuticals. Here we have discovered that norcoclaurine
synthase from Thalictrum flavum (TfNCS) can catalyse the PSR between dopamine and
unactivated ketones, thus facilitating the facile biocatalytic generation of 1,10-disubstituted
THIQs. Variants of TfNCS showing improved conversions have been identiﬁed and used to
synthesize novel chiral 1,10-disubstituted and spiro-THIQs. Enzyme catalysed PSRs with
unactivated ketones are unprecedented, and, furthermore, there are no equivalent
stereoselective chemical methods for these transformations. This discovery advances the
utility of enzymes for the generation of diverse THIQs in vitro and in vivo.
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T
he Pictet–Spengler reaction (PSR) involves the condensa-
tion and ring closure between a b-arylethylamine and
a carbonyl compound, typically an aldehyde1. Ketones can
be employed in PSRs to yield 1,10-disubstituted
tetrahydroisoquinolines (THIQs), which feature a nitrogen subs-
tituted quaternary center (a-tertiary amine). Such structures are
the basis of several natural products and pharmaceutical
compounds including the Erythrina alkaloids and FR115427
(Fig. 1). However, compounds containing a-tertiary amines are
typically challenging to synthesise2, and the use of unactivated
ketones in the Pictet–Spengler reaction has been limited by
their low reactivity and steric bulk.
General chemical strategies for PSRs with unactivated ketones
can involve Brønsted acid catalysis3,4, Lewis acid catalysis5,6 or
use of ﬂuorinated solvents7. However, to our knowledge, there are
no general methods for stereoselective chemical PSRs with
ketones. Importantly, efﬁcient routes to chiral 1,10-disubstituted
THIQs remain a signiﬁcant unsolved challenge within synthetic
chemistry8.
Several enzymes catalysing stereoselective PSRs have been
characterized from plant benzylisoquinoline alkaloid biosynth-
esis9–12 and indole alkaloid biosynthesis13,14. Pictet–Spenglerases
have also been identiﬁed in bacterial secondary metabolism15–17.
The plant enzymes have a central role in engineered microbial
systems for the production of alkaloids18–22. Furthermore,
the wide substrate promiscuity of these enzymes has led to
their use in biocatalytic syntheses, but the carbonyl substrates
employed have always been aldehydes23–32. The only example
of a Pictet–Spenglerase accepting non-aldehyde carbonyl
substrates was the report of a norcoclaurine synthase (NCS)
from Coptis japonica (CjNCS2, also known as CjPR10A) turning
over 4-hydroxyphenylpyruvate and pyruvic acid, activated a-keto
acids10. There have, however, been no previous reports of
enzymatic Pictet–Spengler catalysis with unactivated ketones.
Here we present the ﬁrst examples of enzyme catalysed PSRs
with unactivated ketones. We have discovered that Thalictrum
flavum NCS (TfNCS), the Pictet–Spenglerase involved in
benzylisoquinoline alkaloid biosynthesis, can accept a wide
range of unactivated ketones in vitro in high yields. We have
also identiﬁed TfNCS variants with improved ketone tolerance
and used these enzymes for the facile biocatalytic formation
of novel chiral 1,10-disubstituted- and spiro-THIQs.
Results
Observation of ketone acceptance. Encouraged by the wide
aldehyde substrate scope demonstrated by NCSs27–31, we investigated
their ability to accept ketones as substrates (Fig. 2). First, we tested
WT NCSs D29TfNCS9,31,33 (29 amino-acid N-terminal truncation)
and CjNCS2 (refs 10,28) for the conversion of dopamine 1 and the
ketone 4-hydroxyphenylacetone 2 into a 1,10-disubstituted THIQ
(Fig. 3a). The ketone 2 was selected as it is structurally similar to
the natural NCS aldehyde substrate 4-hydroxyphenylacetaldehyde
(4-HPAA)34. The NCS enzymes were recombinantly expressed
in Escherichia coli and examined as crude lysates (Supplementary
Fig. 1). The lysates were incubated with dopamine 1 and ketone 2,
and reactions were then analysed by HPLC-MS. For reactions
containing D29TfNCS, a new product with an m/z of 286.1 was
observed, corresponding to the 1,10-disubstituted THIQ product 3
(Fig. 3b). This product 3 was not observed in reactions with CjNCS2,
phosphate buffer or the empty vector (EV) control. The formation
of 3 by D29TfNCS was found to be strongly inﬂuenced by the
co-solvent employed, with reactions containing DMSO producing
larger quantities (more than ﬁvefold) of the product 3 than
those with acetonitrile (Supplementary Fig. 2); this was perhaps
a result of enzyme stability effects. The observation that D29TfNCS
could accept ketone 4-hydroxyphenylacetone 2 provided a starting
point for a wider examination of this novel enzyme activity.
TfNCS variant screen. In order to identify the scope of the
NCS ketone PSR, variants of D29TfNCS were screened with
dopamine and a range of ketones (Fig. 4; Supplementary Figs 3 and
4). Enzyme variants tested were rationally chosen based on the
NCS dopamine-ﬁrst mechanism and prior docking studies with the
natural aldehyde substrate 4-HPAA28,31. Previously examined
amino-acid residues that were found to play a minor role in the
enzyme mechanism were targeted (Y108F and D141E/N). Prior
docking studies had also identiﬁed Met-97 as occupying a position
proximal to the iminium intermediate; it was thought that
substitutions of this residue (M97F/L/V) may increase the space
available in the active site for bulkier ketone substrates. The active
site entrance loop region (amino acids 76–80) was also examined as
both experimental and docking studies had suggested this region
inﬂuences the carbonyl substrate acceptance31. Variants with
altered hydrophobic interactions in this loop region were
therefore investigated (L76A/V, A79F/I, F80L).
Along with ketone 2 (Fig. 3), D29TfNCS activity was observed
with the related methyl ketone phenylacetone 4 (Fig. 4).
A number of cyclohexanones also appeared to be turned over
by the enzymes, which was remarkable given the structural
differences between these compounds and the natural substrate.
Enzyme products were observed for cyclohexanone (6), and
4-methyl- (7), 4-tert-butyl- (8) and 4-phenyl- (9) substituted
cyclohexanones (Fig. 4, Supplementary Fig. 3). The single isomer
ketone (3R)-methylcyclohexanone ((R)-10) was also converted
into a new product by the enzymes.
No products were identiﬁed for several other ketones
when incubated with D29TfNCS variants and dopamine
(Supplementary Fig. 4). In most cases, the lack of activity can
be explained by steric effects. Ethyl ketones (3-pentanone) or
very bulky methyl ketones (adamantylmethylketone) did not
appear to be accepted. Although the D29TfNCS variants
accepted 3- and 4-substituted cyclohexanones, substitution
on the 2-position was not accepted, nor was tri-substituted
3,3,5-trimethylcyclohexanone. The less reactive conjugated
ketones were not turned over (acetophenone, cyclohexenone),
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Figure 1 | Pictet–Spengler formation of 1,10-disubstituted
tetrahydroisoquinolines. Examples of 1,10-disubstituted
tetrahydroisoquinolines (THIQs), with the a-tertiary amine moieties
highlighted in blue. FR115427 and dizocilpine are synthetic anticonvulsants.
The Erythrina and spiro-benzylisoquinoline alkaloids are subgroups of plant
benzylisoquinoline alkaloids.
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whilst other ketones (propiophenone, isophorone) were not
accepted presumably due to a combination of steric effects
and lower reactivity.
All enzyme variants examined with ketones 2, 4 and
6-10 showed conversions (Fig. 4b). The variants M97L, M97V,
D141E and D141N showed consistently lower conversions than
WT, perhaps due to the amino-acid substitutions adversely
affecting the enzyme mechanism or structure in a general
manner. For example, the Met-97 side-chain points into
the active site, positioned near to the iminium moiety of the
reaction intermediate. The shortening of this side chain to L or
V may increase the conformational freedom of the iminium
intermediate, thereby reducing catalytic efﬁciency. Also, the
Asp-141 carboxylate is likely to interact electrostatically with
the amino group of the dopamine substrate; variation of this
amino-acid side chain to glutamate (with an extra methylene
group) caused a reduction in conversions, whilst removal of the
charge (D141N) had a more severe effect. Similar effects were
shown previously with the substrates 4-HPAA and hexanal31. The
variants L76V, F80L, M97F and Y108F generally appeared
inferior to wild type (WT) with the methyl ketones (2 and 4),
but for speciﬁc cyclohexanones (6-10) slightly exceeded
WT conversions. The most notable amino-acid substitutions
were those on the Ala-79 residue: A79I gave conversions twice
that of WT for the methyl ketones (2 and 4), whilst A79F showed
increased conversions for all the cyclohexanone substrates (6-10).
Overall, the mutant screening identiﬁed the range of ketones
accepted by D29TfNCS along with variants showing improved
conversions. Enzyme reactions were then scaled-up into
biocatalytic syntheses both in order to fully characterize
the enzyme products and to demonstrate the synthetic potential
of this system.
Biocatalytic formation of chiral 1,10-disubstituted THIQs.
Novel chiral 1,10-disubstituted- THIQs were obtained from
dopamine and methyl ketones via preparative scale (50 mmole)
in vitro biotransformations. The ketones employed were pheny-
lacetone 4 and 4-methoxyphenylacetone 5, and the reactions were
catalysed by the D29TfNCS variant A79I (Fig. 5a). Conversion
yields, based on the depletion of dopamine, were high: 91% and
74% for 4 and 5, respectively. The THIQs were puriﬁed in
good yields as hydrochloride salts using an extraction
method which did not involve chromatographic separation
(method adapted from Maresh et al.29). Isolated yields for the
pure compounds 11 and 12 were 87% and 69%, respectively.
Methyl ketone-derived THIQ products 11 and 12 contained
a chiral a-tertiary amine moiety and optical rotations were
recorded for both compounds indicating a degree of enantiopur-
ity (Fig. 5a). The stereoselectivity of the reactions was investigated
further by determining the enantiomeric excess (e.e.) of (S)-11.
In order to achieve this, rac-11 was required as a racemic
standard, and was obtained via a three step chemical synthesis
(Fig. 5b; synthetic procedure adapted from Horiguchi et al.5).
The synthesis was completed with an overall yield of 11%;
this contrasts with the high yielding one-step enzymatic synthesis
of 11. Comparison of rac-11 and (S)-11 by chiral HPLC revealed
that (S)-11 was formed in 95% e.e. (Supplementary Fig. 5). On the
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Figure 2 | Norcoclaurine synthase activities. Previous work using NCSs demonstrated biocatalytic formation of 1-monosubstituted-THIQs from dopamine
and aldehydes. In this work we demonstrate the biocatalytic route to 1,10-disubstituted THIQs, from dopamine and ketones, via a Pictet–Spengler reaction,
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Figure 3 | NCS activity with 4-hydroxyphenylacetone. (a) Proposed enzyme catalysed Pictet–Spengler condensation between dopamine 1 and an
unactivated ketone (4-hydroxyphenylacetone 2). (b) HPLC analysis of reactions between 1 and 2. Substrates 1 and 2 were incubated together with
phosphate buffer (KPi), control lysate with empty vector (EV), lysate containing D21CjNCS2 or lysate containing D29TfNCS. Formation of a new compound
was observed in the TfNCS sample. When analysed by MS, this compound had an m/z of 286.1, corresponding to THIQ 3.
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basis of the previously observed selectivity of the enzyme with
phenylacetaldehydes (95% e.e., S-isomer)28, S-stereochemistry
was assigned to the enzymatic products (S)-11 and (S)-12. This
e.e. data demonstrated that NCS can perform stereoselective
Pictet–Spengler catalysis with ketones: we know of no chemical or
enzymatic catalysts that have been shown to be capable of such an
activity.
Biocatalytic formation of spiro-THIQs. Novel spiro-THIQs
(13–17) were obtained in a similar manner to that described
above for the chiral 1,10-disubstituted THIQs, though the enzyme
variant A79F was used instead of A79I (Fig. 6). Conversion yields,
based on dopamine depletion, were generally excellent (75–99%),
though isolated yields were signiﬁcantly lower (27–58%). The
syntheses involving methyl ketones (11 and 12) demonstrated
superior puriﬁcation efﬁciency compared to those with
cyclohexanones (13–17). This difference is likely to have been due
to a variation in the extraction efﬁciencies and material lost in
washing procedures, since no alternative reaction products were
observed to account for the consumption of dopamine.
The cyclohexanone-derived compounds isolated (13–17) all
possessed a spiro-fused ring. Products generated from the
4-substituted cyclohexanones (14–16) all had a ﬁxed stereocenter
in the C-4 position, with the substituent exclusively in an
equatorial orientation as determined by 2D NOESY NMR
spectroscopy (Fig. 6a). The product derived from the chiral
ketone (3R)-methylcyclohexanone (R)-10 was exclusively the
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Figure 4 | Ketones screened with D29TfNCS variants. (a) Structures of ketones tested that showed conversion by D29TfNCS variants. Ketones accepted:
4-hydroxyphenylacetone 2*, phenylacetone 4, 4-methoxyphenylacetone 5*, cyclohexanone 6, 4-methylcyclohexanone 7, 4-tert-butylcyclohexanone 8,
4-phenylcyclohexanone 9 and (3R)-methylcyclohexanone (R)-10. (b) Charts showing HPLC product peak area in reactions with dopamine, different
ketones and different D29TfNCS variants (EV, empty vector control). See Supplementary Fig. 3 for representative HPLC chromatograms and Supplementary
Fig. 4 for structures of ketones not accepted by any D29TfNCS variant. *Commercially available ketone 2 (4-hydroxyphenylacetone) was tested in the
initial screen but degradation of the ketone starting material restricted its suitability for use in scale up reactions. Therefore, the more stable ketone 5
(4-methoxy-phenylacetone) replaced ketone 2 in the scale up biotransformations (Fig. 5a).
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(1R,3R)-17 enantiomer, with an equatorial C3-methyl substituent
(Fig. 6b). This was also veriﬁed by 2D NOESY NMR spectro-
scopy, and is the ﬁrst reported (1R)-THIQ to be formed by NCS.
Notably, for all the 3- and 4-substituted cyclohexanones
examined it appeared that the sole product was that with the
substituent in the more stable and less sterically hindered
equatorial conformation.
Active site entrance loop. The active site entrance loop (residues
76–80) appeared to inﬂuence the enzyme tolerance for ketone
substrates. Previously, an amino-acid substitution on this loop
(L76A) was shown to modulate the aldehyde substrate tolerance31.
In the screens using cell lysates here particular variants seemed to
show greater product formation than WT (Fig. 4). To investigate
these further, assays were conducted using known concentrations
of puriﬁed enzymes (Supplementary Fig. 1). These assays
demonstrated that the amino-acid substitutions A79I and A79F
improved conversions for phenylacetone and cyclohexanone
respectively (Supplementary Fig. 6).
In this study, the enzyme CjNCS2 showed poor tolerance
towards ketone substrates. No activity was observed with
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biotransformations. (b) Synthetic route towards rac-11. See Supplementary Fig. 5 for chiral HPLC analysis, Supplementary Methods for full synthetic
procedures, Supplementary Figs 9 and 10 for achiral HPLC analysis, and Supplementary Figs 11-13 for NMR spectra.
HO
HO
NH
HO
HO
NH
HO
HO
NH
t-Bu
HO
HO
NH
Ph
HO
HO
NH1
3
13
ketone: cyclohexanone 6
TfNCS variant: A79F
99% conversion
43% purified yield (HCl salt)  
14
 ketone: 4-methylcyclohexanone 7
TfNCS variant: A79F
99% conversion 
51% purified yield (HCl salt)
15
ketone: 4-tert-butylcyclohexanone 8
TfNCS variant: A79F
75% conversion
33% purified yield (HCl salt) 
 
16
ketone: 4-phenylcyclohexanone 9
TfNCS variant: A79F
82% conversion 
58% purified yield (HCl salt)
(1R,3R)–17
ketone: (3R)-methylcyclohexanone (R)–10
TfNCS variant: A79F
98% conversion 
27% purified yield (HCl salt)
NH
OH
HO
H
H
H
H
HH
H
CH3
H
H
H
H
H
H
H
H
Selected NOEs
a
b
Figure 6 | Biocatalytic formation of spiro-1,10-disubstituted THIQs using D29TfNCS variants. (a) Spiro-THIQ products isolated from biotransformations.
All compounds feature a ﬁxed stereocentre at the C-4 position. (b) Chiral (R)-Spiro-THIQ product (1R,3R)-17 isolated from biotransformation. Important
NOE (nuclear Overhauser effect) correlations are highlighted. See Supplementary Methods for full synthetic procedures, Supplementary Figs 9 and 10 for
HPLC analysis and Supplementary Figs 14-18 for NMR spectra.
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4-hydroxyphenylacetone (Fig. 3b), and with cyclohexanone
puriﬁed CjNCS2 showed only a 6% conversion relative to
WT D29TfNCS (Supplementary Fig. 6b). A major difference
between CjNCS2 and TfNCS is at the aforementioned active site
entrance loop. CjNCS2 has an extra amino acid in this region,
which is likely to affect its structure and interactions with
the reaction intermediates (TfNCS: 76-LPGAF-80, CjNCS2:
71-LPAGIF-76). On the basis of both the improved Ala-79
variant conversions and the poor CjNCS2 conversions, it is
clear that the loop encompassing residues 76–80 plays a key
role in the carbonyl substrate tolerance of NCS.
Computational docking. In order to probe the molecular basis
of the NCS ketone activities, the effects of the amino-acid
substitutions and the stereochemical outcomes of the reactions,
a computational docking study was conducted. The iminium
intermediates of the ketone PSRs were docked into the active
site of the TfNCS crystal structure35. The study revealed
predicted binding modes that corresponded to the NCS
dopamine-ﬁrst enzyme mechanism, in which dopamine is
buried in the active site whilst the ketone R-group is oriented
into the bulk solvent at the active site entrance (Fig. 7;
Supplementary Figs 7 and 8; Supplementary Table 1)28,31.
The mechanistically relevant binding modes of cyclohexanone-
dopamine iminium intermediates showed a nearly identical
arrangement to the natural reaction intermediate (Fig. 7a,b).
Crucially, the iminium nitrogen occupied a position between
Tyr-108 and Glu-110 and the catechol hydroxyl groups were
adjacent to Lys-122. The ketone-derived cyclohexane ring portion
was positioned near to Met-97 and residues on the active site
entrance loop (76–80). The width of the active site tunnel
matched exactly that of the cyclohexanone a-carbons. Certain
substrates that were not accepted by the enzyme in assays, such as
2-substituted cyclohexanones or ethyl ketones, are more sterically
bulky at these a-carbons and this may have inhibited binding.
In contrast there appeared to be limited restriction on
the equatorial 4-subsitutent of the cyclohexanone intermediates
(14–16), which were oriented outside the active site in
the docking binding modes (Fig. 7b; Supplementary Fig. 8).
This can account for the diversity and size of 4-substituents
accepted by the enzyme.
The results of docking methyl ketone intermediates into the
NCS active site also provided mechanistically relevant binding
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Figure 7 | Reaction intermediate binding modes. Iminium reaction intermediates were docked in the TfNCS active site using AutoDock Vina42. The
structure of the docked iminium ligand is shown above a depiction of the mechanistically relevant binding modes. The side chains of mechanistically
important amino acids or amino acids modiﬁed in this study are shown as sticks. (a) Intermediate derived from 4-HPAA, the natural aldehyde substrate. (b)
Intermediate derived from 4-phenylcyclohexanone 9, a representative example of the docking results of cyclohexanone-derived compounds. (c)
Intermediate derived from phenylacetone 4 with trans (E) double bond. (d) Intermediate derived from phenylacetone 4 with cis (Z) double bond. Complete
docking results can be found in Supplementary Figs 7 and 8 and Supplementary Table 1.
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modes in which the catechol hydroxyl was bound to Lys-122
(Fig. 7c,d). However, the cavity between Tyr-108 and Glu-110,
which is typically occupied by the iminium nitrogen was
instead occupied by the a-carbon methyl group. In the
trans-iminium binding modes the iminium nitrogen proton
pointed away from the mechanistically important residues
Glu-110 and Asp-141 (Fig. 7c), whilst for the cis-iminium
binding modes the nitrogen was positioned directly between
Glu-110 and Asp-141 (Fig. 7d). It is not known whether the
cis- or the trans-iminium is the enzymatic reaction intermediate.
Furthermore, the docking results were ambiguous with respect
to the stereochemical outcome of the reaction. Overall, although
the docking of cyclohexanone intermediates ﬁts extremely
well with experimental observations, it appears that the methyl
ketone docking results do not fully account for the observed
enzyme activities.
Discussion
Enzymatic Pictet–Spengler conversion of unactivated ketones is
unprecedented. Reactions with these unactivated ketones are
more energetically and sterically challenging than the previously
described conversions of aldehydes or a-keto acids. It is therefore
remarkable that conversions and yields are so high for such
demanding substrates—indeed the enzyme seems to have
catalytic ability beyond what is necessary for its natural reaction.
Inorganic phosphate is capable of catalysing the aqueous
formation of 1-substituted-THIQs from dopamine and
aldehydes36, yet it cannot turn over ketones. The mechanism of
phosphate catalysis and NCS enzymatic catalysis must therefore
differ. Furthermore, the enzymatic ketone activity does not
appear to have fully co-evolved with aldehyde reactivity, as
demonstrated by poor CjNCS2 conversion of ketones compared
to TfNCS, whereas both of these enzymes show good conversions
of a range of aldehydes27–31. It is not known whether in vivo
conditions in plant vacuoles, where NCS has been shown
to reside11, are conducive to activity with ketones, or whether
this activity is only revealed in vitro.
Amino-acid substitutions in the TfNCS active site modiﬁed
the ketone substrate tolerance of the enzyme. In particular,
variants of Ala-79 demonstrated improved turnover of ketones.
The active site entrance loop (amino acids 76–80) is an exposed
hydrophobic region of the enzyme that interacts with ketone
substrates at initial substrate binding and then as the reaction
progresses. Modiﬁcation of these hydrophobic interactions, and
especially the increase of such interactions through the substitu-
tions A79F and A79I, may improve the afﬁnity of hydrophobic
substrates with the enzyme. This hypothesis is supported
by the docking study which predicted comparatively large
afﬁnities for the bulkier hydrophobic substrates 4-tert-butylcy-
clohexanone 8 and 4-phenylcyclohexanone 9 (Supplementary
Table 1). The increase in side-chain steric interactions caused by
the A79F or A79I substitutions may also aid the reaction
progression by encouraging the reaction intermediate to adopt
a conformation conducive to cyclisation. However, these
hypotheses cannot yet account for the poor ketone activity of
CjNCS2. Our work has also demonstrated that NCS would be
tractable for larger scale mutation and directed evolution studies;
such studies are likely to increase the variety of substrates
(aldehydes and ketones) capable of being accepted by the
enzymes, and will also improve our understanding of the
reaction mechanism.
The activity with substituted cyclohexanones enables the
biocatalytic formation of spiro-THIQs. Compounds with similar
structures are present in plants as part of the Erythrina and spiro-
BIA subfamilies e.g. the schelhammerans or homoerythrinane
alkaloids (Fig. 1a)37,38. Although the biosyntheses of these
compounds have not been fully elucidated, it is known
that these structures are not formed directly via a PSR39,40.
The results here demonstrate that an alternative enzymatic
route to these compounds is feasible. Furthermore, the rigidity
and three-dimensional nature of spirocycles makes them
attractive moieties in drug discovery41, and a facile enzymatic
approach to such structures will be of use in the future.
We have demonstrated the remarkable capacity of NCS to
catalyse the formation of chiral 1,10-disubstituted- and spiro-
THIQs. This enzymatic catalytic activity of NCS with ketones
rivals even the most advanced chemical THIQ Pictet–Spengler
catalysts. Recently, there has been signiﬁcant progress in the
development of benzylisoquinoline alkaloid metabolic engineer-
ing20,21. NCS plays a vital role in these systems and, with this
discovery, can now form the foundation of novel cascade systems
incorporating ketones in biosynthetic pathways. Overall, this
study has considerably expanded the repertoire of accessible
THIQs, opening the door to a vast array of biocatalytically
produced bioactive 1,10-disubstituted THIQs.
Methods
Gene sequences. Codon-optimized genes encoding C-terminal His-tagged
D29TfNCS variants and C-terminal His-tagged codon D21CjNCS2 were obtained
in pJ411 and pD451 vectors respectively (DNA2.0; Menlo Park, CA, USA).
D29TfNCS Met-97 variants were prepared from WT D29TfNCS using QuikChange
Lightening mutagenesis kit (Agilent, Santa Clara, CA, USA) and mutagenesis
primers (Forward: 50-ATTCTGGACNTCACCTTTGTCCCGGGTGAATTCCC
GCAC-30, Reverse: 50-CTACCGCCACAACCATGCTAAGACCTGNAGT
GGAAACAG-30 , purchased from Euroﬁns, Luxembourg). Full-length CjNCS2
used in puriﬁed enzyme assays and was obtained as previously reported28. The
empty vector control used was a pET29a vector. All sequences were veriﬁed
by Sanger sequencing provided by Source BioScience. TfNCS and CjNCS2 protein
sequences can be found on UniprotKB with the identiﬁers Q67A25 and
A2A1A1 respectively.
Protein expression. Plasmids were transformed into E. coli BL21(DE3) cells
by a standard heat-shock protocol. Transformants were inoculated into 20ml of
terriﬁc broth (TB) medium (50 mgml 1 kanamycin; Miller, Merck Millipore).
Starter cultures were incubated 16 h at 37 C, shaking at 250 revmin 1. Fresh
TB media (with 50mgml 1 kanamycin) was inoculated with the overnight culture
(4% v/v inoculant). The cultures were incubated for 2 h at 37 C, followed by 1 h
at 25 C, shaking at 250 revmin 1. Expression was induced by the addition of
isopropyl b-D-1-thiogalactopyranoside (IPTG, ﬁnal concentration 500mM).
Cultures were incubated for 3 h (25 C, 250 revmin 1) before collecting by
centrifugation (10,000 g, 10mins, 4 C). The cell pellets were stored at  20 C
until further processing.
Lysate preparation. Lysates used in initial substrate screens were prepared
from 1ml cultures. Cell pellets underwent ﬁve freeze–thaw cycles before
resuspension in 100 ml 50mM HEPES pH 7.5. The insoluble material was removed
by centrifugation and the supernatant was used in reactions. For larger scale
biotransformations or puriﬁed enzyme assays, cell pellets were resuspended
in 50mM HEPES pH 7.5 (10% of the original culture volume) and sonicated
(10 s ON, 10 s OFF) until homogenous. The insoluble fraction was pelleted by
centrifugation (10,000 g, 30min, 4 C). The supernatant was removed and
ﬁltered through a glass ﬁbre preﬁlter and 0.2 mm cellulose acetate syringe ﬁlter
(Sartorius Stedim Biotech, Go¨ttingen, Germany). The clariﬁed lysate was used
directly in biotransformations or puriﬁed further.
Enzyme purification. The ﬁltered supernatant was passed through a 2ml
Ni-Sepharose column (HP resin, GE) previously equilibrated with binding
buffer (0.1M HEPES, 20mM imidazole, 100mM NaCl, pH 7.5; 10ml), and the
column was then washed with binding buffer (10ml) followed by wash buffer
(0.1M HEPES, 40mM imidazole, 100mM NaCl, pH 7.5; 20ml). The bound
protein was eluted (0.1M HEPES, 500mM imidazole, 100mM NaCl, pH 7.5; 5ml).
The eluent containing pure enzyme was buffer exchanged into assay buffer
(50mM HEPES pH 7.5), using a PD-10 column (GE). Protein purity was
established by SDS–PAGE (Supplementary Fig. 1). Protein concentration was
determined using absorbance at 280 nm. For storage, glycerol was added (10% v/v);
the protein was ﬂash-frozen in liquid nitrogen and stored at  80 C.
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Chemical reagents. All reagents were obtained from commercial sources
(Sigma-Aldrich, St. Louis, MO, USA) and used as received unless otherwise stated.
4-Hydroxyphenylacetone was provided by AldrichCPR and was only of
sufﬁcient purity to use in screens and not in the biotransformations. Dopamine
hydrochloride was provided by Alfa Aesar.
HPLC analysis. Achiral HPLC analysis was performed with a system consisting
of a LC Packing FAMOS Autosampler, a Dionex P680 HPLC Pump, a Dionex
TCC-100 Column oven and a Dionex UVD170U Ultraviolet detector. Separation
conditions: HiChrom ACE C18-5 (150 4.6mm) column, 1mlmin 1 gradient of
H2O (0.1% v/v TFA) and acetonitrile 90:10 to 30:70 over 5min, 30 C, 280 nm
absorbance detection and 20 ml injection volume. Chiral HPLC analysis was
conducted on an Agilent Technologies 1260 Inﬁnity machine with a ultraviolet
detector, a Supelco Astec Chirobiotic T column (25 cm 4.6mm, 5 mm), ﬂow rate
1mlmin 1, at 25 C, eluent ethanol-ammonium acetate (15:85; 5mM, pH 3.5)
and detection at 230 nm.
Chemical analytics. MS analysis was performed in the UCL Chemistry Mass
Spectrometry Facility. Compounds were ionized using electrospray ionization
and detected in positive mode on a Waters LCT Premier XE (3, 11, 12, 17, 18)
or a Q-TOF Agilent 6510 (14, 15, 16). All compounds were identiﬁed by their
[MþH]þ signal. NMR spectra were recorded at 298 K at 600MHz using
a Bruker Avance 600. Chemical shifts (in p.p.m.) are quoted relative to tetra-
methylsilane and referenced to residual protonated solvent. Coupling constants (J)
were measured in Hertz (Hz) and multiplicities for 1H NMR coupling are shown as
s (singlet), d (doublet), t (triplet) and m (multiplet). Two-dimensional COSY,
HSQC, HMBC and NOESY spectra were used for compound identiﬁcation.
Compound screening. For initial detection of activity with 4-hydro-
xyphenylacetone, reactions contained: dopamine 1 10 or 15mM, 4-hydro-
xyphenylacetone 2 10 or 15mM, 10 or 15% v/v DMSO or MeCN co-solvent (when
2 was limiting or in excess, respectively), 50% v/v clariﬁed cell lysate
(for D29TfNCS, D21CjNCS and empty vector control). For phosphate control:
750mM potassium phosphate pH 7 was present, and no cell lysate. Reactions were
incubated for 3 h at 37 C, quenched with HCl (ﬁnal concentration 100mM),
centrifuged and analysed by HPLC. Fractions from the D29TfNCS sample
containing the new compound of interest 3 (retention time (RT)¼ 5.1min) were
collected and analysed by MS. For subsequent screens with D29TfNCS variants:
20% v/v lysate, 15mM dopamine 1, 10mM ketone, 10% v/v DMSO, 37 C, 6 h.
Reactions were quenched with HCl (ﬁnal concentration 100mM), centrifuged
and analysed by HPLC.
Biotransformations. Reactions (5ml) contained: 20% v/v lysate, 5mM ascorbic
acid, 10mM ketone, 15mM dopamine 1, 10% v/v DMSO and 50mM HEPES pH
7.5. The reaction was incubated for 6 h (37 C, 250 revmin 1). The reactions were
stored at  20 C until further processing. For synthesis of 17, conditions were
modiﬁed: 50% v/v lysate, 5mM ascorbic acid, 10mM ketone, 20mM dopamine,
10% v/v DMSO and 50mM HEPES pH 7.5. The reaction was incubated for 16 h
(37 C, 250 rev per min 1). The reaction was centrifuged and ﬁltered before
extraction. Crude conversions were measured by depletion of dopamine using
HPLC analysis. For HPLC traces of crude biotransformations, see Supplementary
Fig. 9.
Compound extraction. The reaction (5ml) was diluted to 10ml with water.
The solution was extracted with ethyl acetate (3 20ml). The fractions were
combined and washed with brine (3 20ml). The organic layer was dried with
magnesium sulfate, ﬁltered and the solvent removed in vacuo. The material was
resuspended in 20ml of a 1:1 mixture of dimethylcarbonate (DMC) and 0.1 M
HCl. The lower organic layer was extracted with 0.1M HCl (2 10ml). The
aqueous layers were combined and water was removed in vacuo (ﬁrst by a rotary
evaporator and the last few millilitres by freeze-drying) to yield the product
as a solid hydrochloride salt. For compounds 14, 15 and 16 dichloromethane
was used in place of DMC.
Complete chemical syntheses and analyses. Detailed synthetic methods,
including the synthesis of rac-11, can be found in the Supplementary Methods. For
HPLC and NMR analyses of puriﬁed compounds see Supplementary Figs 10–18.
Purified enzyme assays. Assays with puriﬁed enzymes contained 15mM
dopamine 1, 10mM ketone, 5mM ascorbate, 50mM HEPES pH 7.5, 10% v/v
DMSO, 20% v/v empty vector lysate, 0.25mgml 1 puriﬁed enzyme. Empty vector
lysate was included to replicate reaction conditions in previous screens
and biotransformations. Reactions were quenched with HCl (ﬁnal concentration
100mM) and analysed by HPLC. Each reaction was performed in duplicate.
Product peak areas were normalized to molar enzyme concentrations and reported
as a proportion of WT D29TfNCS peak area for direct comparison.
Computational docking. Reaction intermediates were energy optimized using
MM2 energy minimization (ChemBio3D, CambridgeSoft). The receptor used
was subunit A from the TfNCS crystal structure 2VQ5 (residues 40–191,
with ligands removed)35. Docking was performed using AutoDock Vina
(exhaustiveness¼ 10)42. Docking box parameters (x,y,z): center (22.27, 21.16,-
27.51); size (23.56, 17.37, 21.78). The exception to the method was the iminium
intermediate of 17—no MM2 minimization was conducted and modiﬁed docking
box parameters were used: center (22.15, 21.15,  27.94), size (16.61, 16.56, 13.43).
For each docking calculation, the nine clusters with the lowest free energy were
visualized and their structure analysed. The mechanistically relevant binding
modes (corresponding to the dopamine-ﬁrst mechanism28,31) were selected, and
their ranking and predicted afﬁnity was recorded (Supplementary Table 1).
Figures of docking results were prepared using UCSF Chimera.
Data availability. The data that support the ﬁndings of this study are available
from the corresponding authors upon reasonable request.
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